"Fundación ACE es una entidad sin ánimo de lucro al servicio de las personas con enfermedad de Alzheimer u otras demencias, y de sus familias. Para hacerlo trabajamos desde 1996 en los campos del diagnóstico, tratamiento, investigación, formación y sensibilización."

During the past decade, Fundació ACE conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundació ACE" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Biogen" with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundació ACE" #1 collaborator was "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Grifols Biologicals, LLC" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Fundació ACE" are "Alzheimer's Disease" (16 trials), "Alzheimer Disease" (4 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Mild Cognitive Impairment" (2 trials) and "Behavioral Variant Frontotemporal Dementia" (1 trials). Many other conditions were trialed in "Fundació ACE" in a lesser frequency.

Most popular intervention types in "Fundació ACE" are "Drug" (24 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Crenezumab" (4 trials), "AVP-786" (2 trials), "Gantenerumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundació ACE" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Fundació ACE". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Fundació ACE, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Fundació ACE, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".